Introduction
Bacteraemic
URINARY TRACT INFECTIONS
Bacteraemic urinary tract infections (BUTI) are frequent, with estimated age-adjusted incidence rates of 20–50 episodes per 100 000 person-years.Fosfomycin remains active against a high proportion of MDR In the FOREST trial, IV fosfomycin was compared with ceftriaxone or meropenem as initial targeted therapy for BUTI due to MDR 